Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An inspiring doctor and scientist of great compassion and intellect, Sir David Weatherall died 8 Dec 2018. A Nuffield Professor of Medicine, founder of the MRC Weatherall Institute of Molecular Medicine and a member of Wellcome’s Board throughout the 1990s, Sir David was instrumental in the creation of MORU back in 1979.

David Weatherall © Credit: University of Exeter CC BY 2.0

Personal Note from Nick White, SE Asia Chairman, MORU Tropical Network

Professor David Weatherall had the greatest influence on my professional life and for that I will be eternally grateful. I went to work for him as a young medical registrar at the Radcliffe Infirmary in Oxford in November 1977 (Tim Peto was my houseman!). Before I went to Oxford I had never heard of him – a reflection of my ignorance as he was already recognised as a brilliant scientist and an emerging leader in British academic medicine. I first met him (we all called him “Prof”) in his book lined office with old leathery chairs and a thick haze of aromatic pipe smoke. I said I wanted to work in the tropics one day, and he told me that he too was interested in tropical medicine and, if possible, would make it happen. He certainly did, and that is why we have a 40 year medical research collaboration based in Thailand and a younger unit in Vietnam.

“Prof” was a brilliant scientist and a perceptive, wise, witty, gentle, compassionate and inspiring physician. He would always enquire about his patient’s social circumstances, and he always examined them. This was an era when senior physicians and surgeons often felt and acted as if they were on a higher plane than the remainder of humanity. David Weatherall hated all that pomp and flummery. He treated everyone as equals. He had a sharp wit, an open and enquiring mind, and he took genuine satisfaction and pride in the success of others. “Prof” inspired and supported a generation of young physicians and scientists. He became the UK’s leading academic clinician, a towering figure in the molecular medicine revolution, an internationally acclaimed scientist, and he was showered with honours and accolades – but his character never changed.

In the late 1970s the Wellcome Trust were seeking to set up a new tropical medicine research unit in East Asia. David Weatherall and Peter Williams (then the Director of the Wellcome Trust) visited several potential collaborating institutions. The Faculty of Tropical Medicine, Mahidol University were interested in this idea and so the Bangkok unit began in 1979 as a collaboration between the Faculty and the Nuffield Department of Medicine, Oxford University headed by David Weatherall. David and Mary Warrell came out to start the research work and I joined them the following year. “Prof” supported us through good times and bad, and although we were successful on the scientific front there were bad times too. We came under a lot of pressure in the late 1980s and I thought we might have to close the Unit and leave Thailand. This led to the founding of the Vietnam unit. David Weatherall in Oxford and Bridget Ogilvie at the Wellcome Trust gave us unwavering support throughout those hard times. Without that we would not have MORU today.

I kept “Prof” up to date with everything that happened in our Unit, and our research progress because he was always interested and encouraging, and he invariably gave wise advice. For such a brilliant mind he was interestingly averse to communications technology – he never mastered computers or e-mail, preferring written letters and personal meetings. As far as I know he never possessed a mobile ‘phone! In scientific and clinical meetings, he would close his eyes, and appear to be completely asleep, but as soon as the speaker stopped he would open his eyes and ask pertinent questions! He was a determined pipe smoker – and on two occasions I witnessed smoke billowing from the pocket of his white coat! Long after he retired I would visit him whenever I was in Oxford to report as he wanted to know how we in MORU were getting on, what advances we had made, and whether there was anything he could do to help. He had a great affection for Thailand, sharing research interests on the study and management of haemoglobinopathies, collaborating with leading figures in Thai medical research, and later advising the Prince Mahidol Award foundation. He was very happy to see the research progress, and particularly the translation to human benefit, and also the career progression of young investigators from Thailand and neighbouring countries. We certainly owe him a lot.

He was a very great man.

Read Sir David’s recollections of how MORU came about (pdf)

Read the News "Sir David Weatherall, 1933-2018" on the Wellcome website

Read what the University of Oxford says about Sir David’s remarkable career.

Similar stories

Study finds almost two-thirds of patients are systematically excluded from drug trials

A new WWARN study has found that nearly two-thirds of the malaria-positive patients who present to health facilities are systematically excluded from “classical” anti-malarial treatment efficacy trials.

New antibiotic combination speeds recovery from severe scrub typhus, which infects 1 million people per year

Treating patients ill with severe scrub typhus – a life-threatening infection that kills tens of thousands of people a year - with a combination of intravenous antibiotics doxycycline and azithromycin is significantly more effective than the current monotherapy of using either drug alone, say researchers in a study published in the New England Journal of Medicine (NEJM).

Watch our webinar - Radical cure of vivax malaria: can we do better?

The three presentations and expert discussion by Dr Rob Commons, Dr Alison Roth and Dr James Watson, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available.

Study supports evidence ivermectin not effective to treat COVID-19

21 Feb 2023 Oxford UK - High doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford-affiliated researchers in a study published today in eLife.

Shobhana Nagraj, Women in Science

Clinical Researcher Shobhana Nagraj, from the Health Systems Collaboratives in Oxford, tells us about the female role models who inspired her to follow her dreams

Phase II Malaria vaccine trial begins in Thailand

The Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.